In vivo transduction of cerebellar Purkinje cells using adeno-associated virus vectors

Molecular Therapy

Volumn 2, Issue 5, 2000, Pages 446-457

  Kaemmerer, William F ^a   Reddy, Rukmini G ^b   Warlick, Christopher A ^a,b   Hartung, Seth D ^a,b   McIvor, R Scott ^a,b   Low, Walter C ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Adeno associated virus; Adenovirus; Deep cerebellar nuclei; Gene transfer; In vivo; Purkinje cells; Transduction

Indexed keywords

ADENO-ASSOCIATED VIRUS; ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5;

BETA GALACTOSIDASE; DNA; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; GREEN FLUORESCENT PROTEIN; PHOTOPROTEIN;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ANIMAL; ARTICLE; CEREBELLUM; CYTOLOGY; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; METABOLISM; MOUSE; PURKINJE CELL; REGULATORY SEQUENCE; TRANSGENE;

ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CEREBELLUM; DEPENDOVIRUS; DNA; GENE EXPRESSION; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; INDICATORS AND REAGENTS; LUMINESCENT PROTEINS; MICE; PURKINJE CELLS; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 0034323465     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2000.0134     Document Type: Article

References (34)

1. Vosby, B. T., and Zoghbi, H. Y. (1997). The CAG/polyglutamine tract diseases: Gene products and molecular pathogenesis. Brain Pathol. 7: 927-942.
2. Davidson, B. L., and Bohn, M. C. (1997). Recombinant adenovirus: A gene transfer vector for study and treatment of CNS diseases. Exp. Neurol. 144: 125-130.
3. Hashimoto, M., Aruga, J., Hosoya, Y., Kanegae, Y., Saito, I., and Mikoshiba, K. (1996). A neural cell-type-specific expression system using recombinant adenovirus vectors. Hum. Gene Ther. 7: 149-158.
4. Terashima, T., Miwa, A., Kanagae, Y., Saito, I., and Okado, H. (1997). Retrograde and anterograde labeling of cerebellar afferent projection by the injection of recombinant adenoviral vectors into the mouse cerebellar cortex. Anat. Embryol. 196: 363-382.
5. McCown, T. J., Xiao, X., Li, J., Breese, G. R., and Samulski, R. J. (1996). Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res. 713: 99-107.
6. Akli, S., Caillaud, C., Vigne, E., Stratford-Perricaudet, L. D., Poenaru, L., Perricaudet, M., Kahn, A., and Peschanski, M. R. (1993). Transfer of a foreign gene into the brain using adenoviral vectors. Nat. Genet. 3: 224-228.
7. Chamberlin, N. L., Du, B., deLacalle, S., and Saper, C. B. (1998). Recombinant adeno-associated virus vector: Use for transgene expression and anterograde tract tracing in the CNS. Brain Res. 793: 169-175.
8. Kaplitt, M., Leone, P., Samulski, R., Xiao, X., Pfaff, D., O'Malley, K., and During, M. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat. Genet. 8: 148-154.
9. Mandel, R. J., Rendahl, K. G., Spratt, S. K., Snyder, R. O., Cohen, L. K., and Leff, S. E. (1998). Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's disease. J. Neurosci. 18: 4271-4284.
10. Bartlett, J. S., Samulski, R. J., and McCown, T. J. (1998). Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum. Gene Ther. 9: 1181-1186.
11. Hartung, S. D., Reddy, R. G., Whitley, C. B., and McIvor, R. S. (1999). Enzymatic correction and cross-correction of mucopolysaccharidosis type I fibroblasts by adeno-associated virus-mediated transduction of the alpha-L-iduronidase gene. Hum. Gene Ther. 10: 2163-2172.
12. Xiao, X., Snyder, R. O., and Samulski, R. J. (1996). Production of recombinant adeno-associated viral vectors. In Current Protocols in Human Genetics, pp. 12.1-12.1.23, Wiley, New York.
13. Wang, X. S., Khuntirat, B., Qing, K., Ponnazhagan, S., Kube, D. M., Zhou, S., Dwarki, V. J., and Srivastava, A. (1998). Characterizations of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination. J. Virol. 72: 5472-5480.
14. Zolotukhin, S., Byrne, B., Mason, E., Zolotukhin, I., Potter, M., Chesnut, K., Summerford, C., Samulski, R., and Muzyczka, N. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6: 973-985.
15. Klein, R. L., Meyer, E. M., Peel, A. L., Zolotukhin, S., Meyers, C., Muzyczka, N., and King, M. A. (1998). Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp. Neurol. 150: 183-194.
16. Grimm, D., Kern, A., Rittner, K., and Kleinschmidt, J. (1998). Novel tools for production and purification of recombinant AAV vectors. Hum. Gene Ther. 9: 2745-2760.
17. Stratford-Perricaudet, L. D., Makeh, I., Perricaudet, M., and Briand, P. (1992). Widespread long-term gene transfer to mouse skeletal muscles and heart. J. Clin. Invest. 90: 626-630.
18. Caddy, K. W. T., and Biscoe, T. J. (1979). Structural and quantitative studies in the normal C3H and Lurcher mutant mouse. Philos. Trans. R. Soc. London B Biol. Sci. 287: 167-201.
19. Qiu, J., Handa, A., Kirby, M., and Brown, K. (2000). The interaction of heparin sulfate and adeno-associated virus 2. Virology 269: 137-147, doi:10.1006/viro.2000.0205.
20. Bartlett, J., Wilcher, R., and Samulski, R. (2000). Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J. Virol. 74: 2777-2785.
21. Summerford, C., Bartlett, J., and Samulski, R. (1999). AlphaVbeta5 integrin: A coreceptor for adeno-associated virus type 2 infection. Nat. Med. 5: 78-82.
22. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., and Srivastava, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5: 71-77.
23. Soussi-Yanicostas, N., Hardelin, J., Arroyo-Jimenez, M., Ardouin, O., Legouis, R., Levilliers, J., Traincard, F., Betton, J., Cabanie, L., and Petit, C. (1996). Initial characterization of anosmin-1, a putative extracellular matrix protein synthesized by definite neuronal cell populations in the central nervous system. J. Cell Sci. 109: 1749-1757.
24. Noda, Y., Nakata, T., and Hirokawa, N. (1993). Localization of dynamin: Widespread distribution in mature neurons and association with membranous organelles. Neuroscience 55: 113-127.
25. Powell, K., and Robinson, P. (1995). Dephophin/dynamin is a neuronal phosphoprotein concentrated in nerve terminals: Evidence from rat cerebellum. Neuroscience 64: 821-833.
26. Pinkstaff, J., Detterich, J., Lynch, G., and Gall, C. (1999). Integrin subunit gene expression is regionally differentiated in adult brain. J. Neurosci. 19: 1541-1556.
27. Fuxe, K., Tinner, B., Zoli, M., Pettersson, R., Baird, A., Biagini, G., Chadi, G., and Agnati, L. (1996). Computer-assisted mapping of basic fibroblast growth factor immunoreactive nerve cell populations in the rat brain. J. Chem. Neuroanat. 11: 13-35.
28. Cordon-Cardo, C., Vlodavsky, I., Haimovitz-Friedman, A., Hicklin, D., and Fuks, Z. (1990). Expression of basic fibroblast growth factor in normal human tissues. Lab. Invest. 63: 832-840.
29. Matsuda, S., Okumura, N., Yoshimura, H., Koyama, Y., and Sakanaka, M. (1992). Basic fibroblast growth factor-like immunoreactivity in Purkinje cells of the rat cerebellum. Neuroscience 50: 99-106.
30. German, C. M., Gies, D., McCray, G., and Huang, M. (1989). The human cytomegalovirus major immediate early promoter can be trans-activated by adenovirus early proteins. Virology 171: 377-385.
31. Metcalf, J. P., Monick, M. M., Stinski, M. F., and Hunninghake, G. W. (1994). Adenovirus E1A 13S gene product up-regulates the cytomegalovirus major immediate early promoter. Am. J. Respir. Cell Mol. Biol. 10: 448-452.
32. Shirahata, S., Watanabe, J., Teruya, K., Yano, T., Osada, K., Ohashi, H., Tachibana, H., Kim, E. H., and Murakami, H. (1995). E1A and ras oncogenes synergistically enhance recombinant protein production under control of the cytomegalovirus promoter in BHK-21 cells. Biosci. Biotechnol. Biochem. 59: 345-347.
33. Klein, R. L., Muir, D., King, M. A., Peel, A. L., Zolotukhin, S., Moller, J. C., Kruttgen, A., Heymach, J. V., Muzyczka, N., and Meyer, E. M. (1999). Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain. Neuroscience 90: 815-821.
34. Peel, A. L., Zolotukhin, S., Schrimsher, G. W., Muzyczka, N., and Reier, P. J. (1997). Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type specific-promoters. Gene Ther. 4: 16-24.